Theriva Biologics, Inc. — Director's Dealing 2010

Mar 25, 2010

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: ADEONA PHARMACEUTICALS, INC. (AEN)
CIK: 0000894158
Period of Report: 2010-03-16

Reporting Person: Riley Jeffrey Scott (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$1.11	2020-03-15	Common Stock (25000)		Direct